தேடல் முடிவுகள் - Benoit Rive

Estimating the benefit of esketamine nasal spray versus real-world treatment on patient-reported functional remission: results from the ICEBERG study மூலம் Albino J. Oliveira-Maia, Albino J. Oliveira-Maia, Benoît Rive, Yordan Godinov, Siobhán Mulhern-Haughey

முழு உரையை பெறுங்கள்

Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression மூலம் Kristin Clemens, Amanda Teeple, Benoit Rive, Noam Kirson, Urvi Desai, Jason Doran, Diab Eid, Alice Qu, Hannah Bowrey, Kruti Joshi

Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression:... மூலம் Albino J. Oliveira-Maia, Albino J. Oliveira-Maia, Benoit Rive, Joachim Morrens, Yordan Godinov, Jedelyn Cabrieto, Nolen Perualila, Siobhán Mulhern-Haughey

முழு உரையை பெறுங்கள்

ICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression in... மூலம் Albino J. Oliveira-Maia, Albino J. Oliveira-Maia, Joachim Morrens, Benoit Rive, Yordan Godinov, Jedelyn Cabrieto, Nolen Perualila, Sebastien Barbreau, Siobhán Mulhern-Haughey

முழு உரையை பெறுங்கள்

Trajectory of response to esketamine nasal spray for treatment resistant depression: Findings from ESCAPE-TRD மூலம் Allan H. Young, Lucie Bartova, Narcís Cardoner, Koen Demyttenaere, Andrea Fagiolini, Yordan Godinov, José Felipe Golib Dzib, Christian von Holt, Roger S. McIntyre, Albino J. Oliveira-Maia, Benoit Rive, Philip Gorwood

முழு உரையை பெறுங்கள்